Dimitri Daldegan-Bueno
Research associate at the University of Auckland's Hugh Green Foundation Addiction Research Chair program
Data updated
Research Footprint
Dimitri Daldegan-Bueno appears in 7 tracked papers (2020–2026), most studied alongside LSD and Ayahuasca, across Depressive Disorders, Healthy Volunteers and Major Depressive Disorder (MDD).
Most-cited paper: LSD and creativity: Increased novelty and symbolic thinking, decreased utility and convergent thinking (41 citations).
Frequent co-authors: Luiz Tófoli, Suresh Muthukumaraswamy and Anna Forsyth.
Background & Research
Dimitri Daldegan-Bueno is a psychologist with graduate training in psychobiology and a research focus on therapeutic effects of psychoactive substances, especially ayahuasca, LSD, and cannabis. He has been described as a research associate in the Hugh Green Foundation Addiction Research Chair program at the University of Auckland, and he has also been associated with psychedelic research in Brazil and New Zealand.
Key Impact
He is a coauthor on multiple psychedelic clinical and translational studies, including LSD microdosing trials for major depressive disorder and work on ayahuasca preparation and pharmacology.
Collaboration Network
17 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Top Collaborators
Affiliations
Institutions, companies, and organisations Dimitri Daldegan-Bueno is associated with.
University of Auckland
The University of Auckland hosts academic psychedelic research activity, including work led by Professor Suresh Muthukumaraswamy on LSD microdosing and related mental health applications.
View stakeholder →Universidade Estadual de Campinas (UNICAMP) / ICARO
Universidade Estadual de Campinas (UNICAMP) is home to ICARO, the Interdisciplinary Cooperation for Ayahuasca Research and Outreach, a research group based at the School of Medical Sciences focused on interdisciplinary ayahuasca research and outreach. ICARO has organized academic programming on ayahuasca and supports scientific and translational work on the plant medicine and related psychedelic topics.
View stakeholder →